HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Topicals In Trouble? TRIA Skin Rejuvenating Laser To Launch OUS

This article was originally published in The Rose Sheet

Executive Summary

TRIA Beauty seeks “growth, growth and more growth” as it prepares to launch its anti-aging laser for home use in markets outside of the U.S. If the firm delivers on its efficacy claims, President and CEO Kevin Appelbaum expects users to reevaluate their topical product use, as some elements of their regimens may no longer be necessary.

You may also be interested in...



Tria Launches Home-Use Laser For Skin Rejuvenation In U.K.

Tria Beauty’s Skin Rejuvenating Laser launches to U.K. consumers through the firm’s website and Selfridges department stores. The device offers a more convenient and economical alternative to professional laser therapy or a means of extending the benefit of in-office treatments, the company says.

LightStim Device For “Full-Face Wrinkles” Generates Acquisition Interest

LED Intellectual Properties’ receipt of 510(k) clearance for its LightStim device, designed to treat “full-face wrinkles,” has not gone unnoticed by personal-care firms looking to enter or grow their stake in the burgeoning aesthetic device market.

Unilever/Cynosure Prep Home Anti-Wrinkle Device For Market Entry

Developed under a partnership between Unilever and Cynosure and recently greenlighted by FDA, the Illuminage diode laser is indicated for the treatment of periorbital and perioral wrinkles at home. Firms plan to launch the product in 2013 in a market expected to grow substantially over the next few years.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel